Head and Neck Cancer Clinical Trials in Besançon
2 recruitingBesançon, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
Head and Neck CancerRenal Cell CarcinomaLung Cancer Metastatic
UNICANCER646 enrolled40 locationsNCT05078047
Recruiting
Not Applicable
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
Lung CancerHead and Neck Cancer
Centre Hospitalier Universitaire de Besancon220 enrolled4 locationsNCT03117946